NDC product
Zoledronic Acid
NDC 69367-190 · Westminster Pharmaceuticals, LLC
Key facts
| Product NDC | 69367-190 |
|---|---|
| Proprietary name | Zoledronic Acid |
| Nonproprietary name | Zoledronic Acid |
| Substances | ZOLEDRONIC ACID |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Westminster Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA202923 |
| Pharmacologic classes | Bisphosphonate [EPC], Diphosphonates [CS] |
| Marketing start | Feb 2, 2023 |
| Marketing end | Dec 1, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory